Bristol-Myers Squibb CompanyBMYNYSE
LOADING
|||
BMYCash Generation Expanding
Trending higher, above historical average, strong compound growth.
Left:
|||
Operating cash flow minus capital expenditures
Latest
$13.94B
↑ 59% above average
Average (9y)
$8.79B
Historical baseline
Range
High:$15.23B
Low:$1.28B
CAGR
+30.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $13.94B | +10.2% |
| 2023 | $12.65B | +5.9% |
| 2022 | $11.95B | -21.6% |
| 2021 | $15.23B | +14.5% |
| 2020 | $13.30B | +80.3% |
| 2019 | $7.37B | +20.6% |
| 2018 | $6.12B | +44.9% |
| 2017 | $4.22B | +129.0% |
| 2016 | $1.84B | +43.4% |
| 2015 | $1.28B | - |